Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIBRANT: Verekitug in Chronic Rhinosinusitis With Nasal Polyps
NCT06164704Phase 2Completed
- Sponsor
- Upstream Bio
- Start
- Dec 2023
- Primary completion
- Jul 2025
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of vereckitug in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Upstream Bio. Started Dec 2023; status: completed.
02
Drugs
vereckitug
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT06164704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06164704.